» Articles » PMID: 10101983

Barriers to Follow-up of Abnormal Papanicolaou Smears in an Urban Community Health Center

Overview
Journal Arch Fam Med
Specialty Public Health
Date 1999 Apr 2
PMID 10101983
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To determine factors predictive of failure to return for colposcopy among women with significant abnormalities on Papanicolaou smears in a high-risk clinical population.

Design: Telephone survey.

Setting: An urban community health center.

Participants: Two hundred seventy-nine women randomly selected from all women seen at the health center with abnormal Papanicolaou smears requiring colposcopy during 1993 to 1994. Six (2%) refused participation, and 19% could not be reached for inclusion. Subjects were mostly minority women receiving Medicaid.

Main Outcome Measure: Completion of colposcopy.

Results: Of the 279 selected women, 79% were interviewed. The rate of adherence with colposcopy was 75% for the respondents. Women who did not know the results of their smear or who incorrectly understood their results were significantly less likely to return for colposcopy (P = .001). Younger women, especially teenagers, were less likely to return (P = .02). Socioeconomic status, education, primary language, health beliefs, fear of cancer, and clinician's gender or discipline were not associated with rate of follow-up. Barriers involving transportation, child care, and insurance also did not predict follow-up.

Conclusions: Effective communication of results is the most important factor related to follow-up after abnormal Papanicolaou smear in this setting. In other settings, other factors may be of greater importance.

Citing Articles

Prediction of Patient's Adherence to the Post-Intubation Tracheal Stenosis Follow-up Plan in Iran: Application of two Data Mining Techniques.

Farzanegan B, Farzanegan R, Shadmehr M, Lajevardi S, Niakan Kalhori S Tanaffos. 2021; 19(4):330-339.

PMID: 33959170 PMC: 8088141.


Performance of p16INK4a ELISA as a primary cervical cancer screening test among a large cohort of HIV-infected women in western Kenya: a 2-year cross-sectional study.

Wu T, Smith-McCune K, Reuschenbach M, von Knebel Doeberitz M, Maloba M, Huchko M BMJ Open. 2016; 6(9):e012547.

PMID: 27625065 PMC: 5030582. DOI: 10.1136/bmjopen-2016-012547.


Evaluating the stage of change model to a cervical cancer screening intervention among Ohio Appalachian women.

Krok-Schoen J, Oliveri J, Young G, Katz M, Tatum C, Paskett E Women Health. 2015; 56(4):468-86.

PMID: 26479700 PMC: 4928634. DOI: 10.1080/03630242.2015.1101736.


Psychosocial barriers to follow-up adherence after an abnormal cervical cytology test result among low-income, inner-city women.

Hui S, Miller S, Wen K, Fang Z, Li T, Buzaglo J J Prim Care Community Health. 2014; 5(4):234-41.

PMID: 24718518 PMC: 4169747. DOI: 10.1177/2150131914529307.


Patient barriers to follow-up care for breast and cervical cancer abnormalities.

Tejeda S, Darnell J, Cho Y, Stolley M, Markossian T, Calhoun E J Womens Health (Larchmt). 2013; 22(6):507-17.

PMID: 23672296 PMC: 3678568. DOI: 10.1089/jwh.2012.3590.